Target intelligence / Profile preview

Homocysteine metabolism pathway enzyme

Molecular classification
Enzyme
01

Overview

The term "Homocysteine metabolism pathway enzymes" refers collectively to a group of enzymes responsible for the conversion and regulation of homocysteine, a sulfur-containing amino acid that is central to methionine and cysteine metabolism. The two main branches are: 1. Remethylation Pathway – Converts homocysteine back to methionine using 5-methyltetrahydrofolate as a methyl donor via the enzyme methionine synthase, which requires vitamin B12 as a cofactor. The production of 5-methyltetrahydrofolate is catalyzed by methylenetetrahydrofolate reductase (MTHFR), an enzyme whose genetic variants can significantly affect plasma homocysteine levels. 2. Transsulfuration Pathway – Converts homocysteine into cystathionine via cystathionine β-synthase (CBS), then further into cysteine by cystathioninase/cystathionin γ‐lyase; both steps require vitamin B6 as a cofactor. Disruption in these pathways—due to genetic mutations or nutritional deficiencies—can lead to elevated plasma homocysteine (hyperhomocysteinemia), which is associated with increased risk for cardiovascular diseases, neurodegeneration, and congenital anomalies. Therapeutic interventions often involve supplementation with folic acid, vitamins B6/B12, or betaine. Note on correctness: This entry refers not to a single molecular target but rather an entire class/pathway comprising multiple distinct enzymes such as MTHFR, CBS, and others. For structured data purposes it would be more accurate—and scientifically useful—to specify individual targets like "Methylenetetrahydrofolate reductase" or "Cystathionine beta-synthase" rather than this collective term.

Other names
Enzymes of homocysteine metabolismHomocysteine pathway enzymesMethionine cycle enzymesTranssulfuration pathway enzymes
02

Mechanism of action

Cofactor supplementation to enhance enzymatic activity or bypass deficiencies in the remethylation or transsulfuration pathways

03

Biological functions

Amino acid metabolismMethylation reactionsRedox homeostasisCellular antioxidant defense
04

Disease associations

Cardiovascular diseaseNeurodegenerative diseaseCongenital metabolic disorders (e.g., homocystinuria)Other (including vascular and developmental disorders)
05

Safety considerations

Risk of masking vitamin B12 deficiency with folic acid therapy
06

Interacting drugs

Folic acid (vitamin B9)

3 more in the full profile.

07

Biomarkers

Plasma total homocysteine concentration

Beyond the preview

Go deeper on Homocysteine metabolism pathway enzyme.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Homocysteine metabolism pathway enzyme.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call